Leadership in health care private equity since 1986

The Latest News

April 01, 2012

Synageva BioPharma and Mitsubishi Tanabe Pharma Corporation Expand Development Collaboration with Second Program>

Synageva BioPharma Corp. (“Synageva”) announced today an expansion of its previous collaboration with Mitsubishi Tanabe Pharma Corporation (Head Office; Osaka, Japan, “MTPC”) to develop a second protein therapeutic for an undisclosed orphan disease using Synageva’s product development capabilities and proprietary protein expression platform. 

March 15, 2012

Synageva BioPharma Reports 2011 Full Year Financial Results>

 

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA) today reported 2011 full year financial results and provided 2012 financial guidance. “Strengthened balance sheet enables a focus on key objectives--Adult LAL Deficiency patients continue to enroll into extension study”. 

March 13, 2012

Graybar Engages SupplyPro to Provide Industry-Leading Point-of-Use Vending Solutions to Customers>

 

SupplyPro today announced that Graybar has become an approved reseller of the SupplyPro vending solutions. Graybar, a leading distributor of electrical, communications and data networking products and provider of related supply chain management and logistics services, is dedicating sales and marketing resources to establish a vending program to serve the needs of its client-base.

 

February 28, 2012

Synageva BioPharma to Present at the Cowen and Company 32nd Annual Healthcare Conference>

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), today announced that it will be presenting at the upcoming Cowen and Company 32nd Annual Healthcare Conference. Sanj K. Patel, President and Chief Executive Officer of Synageva, is scheduled to present on Tuesday, March 6, 2012, at 9:20 AM Eastern Standard Time.  

December 05, 2011

Estech Announces Start of Patient Enrollment in HISTORIC-AF European Multi-center Staged Hybrid Ablation Study>

Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORICAF European multi-center staged hybrid ablation clinical study. Ten centers will participate in the study which is expected to enroll over 100 patients in Italy, Germany, the United Kingdom, France, and Poland.

November 13, 2011

Synageve BioPharma Announces Completion of Merger with Trimeris>

Synageva BioPharma Corp., a clinical stage biopharmaceutical company developing therapeutic products for rare disorders has announced that following the special meeting of shareholders on November 2, 2011, the Synageva and Trimeris, Inc. merger has closed.

October 24, 2011

New SupplyPro Distributor Command Center Provides Anytime-Anywhere Data Access and Materials Visibility Across All Customers and Locations Using Point-of-Use Technologies>

New SupplyPro Distributor Command Center Provides Anytime-Anywhere Data Access and Materials Visibility Across All Customers and Locations Using Point-of-Use Technologies

October 18, 2011

Vidacare— Vascular Access Using Intraosseous (Inside the Bone) Space Less Expensive and Equally Effective Compared to Central Venous Catheters in Hospital Setting>

Vidacare— Vascular Access Using Intraosseous (Inside the Bone) Space Less Expensive and Equally Effective Compared to Central Venous Catheters in Hospital Setting

October 07, 2011

Impulse Monitoring - Acquisition of Impulse Monitoring Inc. by NuVasive, Inc. Completed>

Impulse Monitoring, Inc. (IMI) today announced that the agreement to be acquired by NuVasive, Inc. (Nasdaq: “NUVA”), had closed. Going forward, IMI will continue to exclusively provide neuromonitoring services as an independent subsidiary of a larger organization.